Compare ACOG & AMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ACOG | AMTX |
|---|---|---|
| Founded | 2000 | 2005 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Major Chemicals |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 129.4M | 98.6M |
| IPO Year | N/A | 2023 |
| Metric | ACOG | AMTX |
|---|---|---|
| Price | $5.75 | $2.29 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $18.00 | $17.00 |
| AVG Volume (30 Days) | 70.5K | ★ 623.1K |
| Earning Date | 01-01-0001 | 06-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $77,194,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $132.35 | $139.04 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 174.60 |
| 52 Week Low | $3.75 | $1.22 |
| 52 Week High | $10.88 | $3.66 |
| Indicator | ACOG | AMTX |
|---|---|---|
| Relative Strength Index (RSI) | 50.51 | 80.59 |
| Support Level | $5.16 | $2.13 |
| Resistance Level | $6.67 | $2.84 |
| Average True Range (ATR) | 0.44 | 0.13 |
| MACD | -0.00 | 0.08 |
| Stochastic Oscillator | 41.03 | 88.22 |
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.
Aemetis Inc is an renewable fuel and biochemicals company focused on the production of renewable fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products through the conversion of first-generation ethanol and biodiesel plants into biorefineries. It owns and operates an approximately 65 million gallon per year ethanol production facility located in Keyes, California. In addition to low carbon renewable fuel ethanol, the Keyes Plant produces Wet Distillers Grains, Distillers Corn Oil, and Condensed Distillers Solubles, all of which are sold to local dairies and feedlots as animal feed. It operates in the reportable geographic segments of North America and India.